ArmonAir Digihaler (fluticasone propionate inhalation powder)
Title: ArmonAir Digihaler (fluticasone propionate inhalation powder)Category: MedicationsCreated: 10/2/2020 12:00:00 AMLast Editorial Review: 10/2/2020 12:00:00 AM (Source: MedicineNet Asthma General)
Source: MedicineNet Asthma General - October 2, 2020 Category: Respiratory Medicine Source Type: news

ArmonAir Digihaler (Fluticasone Propionate Powder for Inhalation) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 25, 2020 Category: Drugs & Pharmacology Source Type: news

FDA Approves Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) for the Treatment of Asthma
London UK 9 September 2020 -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) announced the US Food and Drug Administration (FDA) has approved a new indication for Trelegy Ellipta (fluticasone furoate / umeclidinium /... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 9, 2020 Category: Drugs & Pharmacology Source Type: news

Lannett Signs Agreement To Be Exclusive Distributor Of Generic Flovent(R) Diskus(R)
Company Extends Distribution Term for Generic ADVAIR DISKUS® PHILADELPHIA, Aug. 17, 2020 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreemen... Biopharmaceuticals, Generics, Distribution Lannett Company, Flovent, Diskus, Fluticasone Propionate Powder Inhaler (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 17, 2020 Category: Pharmaceuticals Source Type: news

Fluticasone Propionate Orally Disintegrating Tablets for EoE Fluticasone Propionate Orally Disintegrating Tablets for EoE
A novel fluticasone propionate formulation which dissolves in the mouth and is swallowed without liquids is under investigation for the treatment of eosinophilic oesophagitis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 22, 2020 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Pharmascience Inc. Launches pms-FLUTICASONE PROPIONATE/SALMETEROL DPI for the Maintenance Treatment of Asthma and COPD
MONTREAL, March 18, 2020 -- (Healthcare Sales & Marketing Network) - Pharmascience Inc. is proud to bring to market a new product for the maintenance treatment of asthma and COPD. pms-FLUTICASONE PROPIONATE/SALMETEROL DPI, a generic alternative to ADVAIR ... Biopharmaceuticals, Generics, Drug Delivery, Product Launch Pharmascience, FLUTICASONE, SALMETEROL, ADVAIR DISKUS, COPD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 18, 2020 Category: Pharmaceuticals Source Type: news

Airduo Digihaler (Fluticasone Propionate and Salmeterol Inhalation Powder) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 6, 2020 Category: Drugs & Pharmacology Source Type: news

Dymista (azelastine hydrochloride and fluticasone propionate)
Title: Dymista (azelastine hydrochloride and fluticasone propionate)Category: MedicationsCreated: 4/20/2015 12:00:00 AMLast Editorial Review: 12/2/2019 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - December 2, 2019 Category: Allergy & Immunology Source Type: news

Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS(R)
PHILADELPHIA, Oct. 1, 2019 -- (Healthcare Sales & Marketing Network) -- Lannett Company, Inc. (NYSE: LCI) today announced that it has entered into an exclusive U.S. distribution agreement for the therapeutically equivalent generic of ADVAIR DISKUS® (F... Biopharmaceuticals, Generics, Distribution Lannett Company, ADVAIR DISKUS, Fluticasone Propionate (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 1, 2019 Category: Pharmaceuticals Source Type: news

azelastine hydrochloride and fluticasone propionate (Dymista)
Title: azelastine hydrochloride and fluticasone propionate (Dymista)Category: MedicationsCreated: 4/20/2015 12:00:00 AMLast Editorial Review: 8/5/2019 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - August 5, 2019 Category: Allergy & Immunology Source Type: news

fluticasone furoate and vilanterol inhalation powder (Breo Ellipta)
Title: fluticasone furoate and vilanterol inhalation powder (Breo Ellipta)Category: MedicationsCreated: 6/12/2013 12:00:00 AMLast Editorial Review: 7/19/2019 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - July 19, 2019 Category: Respiratory Medicine Source Type: news

FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma
JERUSALEM and PARSIPPANY, N.J., July 15, 2019– Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that the U.S. Food and Drug Administration (FDA) has approved AirDuo® Digihaler™ (fluticasone propionate 113... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 15, 2019 Category: Drugs & Pharmacology Source Type: news

fluticasone furoate nasal spray (Veramyst)
Title: fluticasone furoate nasal spray (Veramyst)Category: MedicationsCreated: 3/2/2005 12:00:00 AMLast Editorial Review: 7/5/2019 12:00:00 AM (Source: MedicineNet Allergies General)
Source: MedicineNet Allergies General - July 5, 2019 Category: Allergy & Immunology Source Type: news

Apotex Corp. Issues Voluntary Nationwide Recall of Fluticasone Propionate Nasal Spray USP 50 mcg Per Spray 120 Metered Sprays Due to Potential for Small Glass Particles
Apotex Corp. is voluntarily recalling one (1) lot of Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, 120 Metered Sprays, to the consumer level. The Fluticasone Propionate Nasal Spray USP 50 mcg per spray 120 Metered Sprays has been found to contain small glass particles. The glass particles could block the actuator and impact the functionality of the pump. The issue was discovered through a customer complaint. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 23, 2019 Category: Drugs & Pharmacology Authors: FDA Source Type: news